News

Common allergy medication’s risks outweigh its usefulness, experts say
When it comes to treating an allergic reaction to food with Benadryl, this doctor says, “It’s time to move on.” ...
ClearBridge International Growth EAFE Q2 2025 Portfolio Positioning
ClearBridge Investments reshaped its Q2 EAFE portfolio with bold moves in utilities, defense, and gold. Discover the strategy ...
Eskay Mining Announces Non-Brokered Charity Flow-Through Private Placement of up to $2 million
TORONTO, ON / ACCESS Newswire / August 1, 2025 / Eskay Mining Corp. (“Eskay” or the “Company”) (TSXV:ESK)(OTC ...
CoTec Holdings to Host Investor Update
VANCOUVER, BC / ACCESS Newswire / July 29, 2025 / CoTec Holdings Corp. (TSXV:CTH)(OTCQB:CTHCF) (“CoTec” or the “Company”) is ...
CoreWeave's $9 billion offer for Core Scientific faces backlash - report
Certain Core Scientific shareholders are expressing strong opposition over CoreWeave's (NASDAQ:CRWV) proposed $9 billion ...
Peabody maintained high-risk Buy at Jefferies with Anglo deal pending
Peabody Energy (NYSE:BTU) +3.9% in Monday's trading as Jefferies maintained its "high risk/hgih reward" Buy rating, ...
Organto Foods Inc. Announces Resumption of Trading on the OTCQB Venture Market
Organto Foods Inc. (TSXV:OGO)(OTCQB:OGOFF), is pleased to announce that its shares will resume trading on the OTCQB Venture Market in the United States beginning August 5, 2025, under the ticker ...
Senzime Secures TetraGraph Installations Across All Sites of World-Leading US Hospital System
UPPSALA, SE / ACCESS Newswire / August 5, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime today announced another strategic ...
XOP: Time To Buy O&G Producers
XOP is well-positioned to benefit from favorable U.S. energy policy shifts. Here's what investors need to know before buying ...